INS and Hypoglycemia: indicate that insulin analog initiation therapy activates lipid metabolism via up-regulating cholesteryl ester transfer protein (CETP) and can increase HDL levels (44, 45).In patients with insulinoma, islet cells can continuously secrete a large amount of insulin, resulting in hypoglycemia.